Abstract
New thiazole and 1,3,4-thiadiazole derivatives were synthesized from the reaction of hydrazonoyl halides and each of 3-(4-fluorophenyl)-3,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-2(1H)-carbothioamide and (E)-3-[mercapto(phenylamino)methylene]-thiochroman-4-one, respectively. The structures of all the newly synthesized compounds were established by elemental and spectral analyses. All of the synthesized compounds were tested for anticancer activity against colon cancer cell line HT29, human breast cancer cells MCF-7 and human hepatocellular carcinoma cell line HepG2. Many derivatives of the tested compounds showed moderate to high anticancer activity. Also, molecular docking against HER2 kinase domain revealed high free binding energy and good binding mode. The structure activity relationship (SAR) of tested compounds was studied.
Keywords: Carbothioamides, hydrazonoyl halides, benzosuberone, thiazoles, thiadiazoles, antitumor agents.
Current Organic Synthesis
Title:Hydrazonoyl Halides as Precursors for Synthesis of Bioactive Thiazole and Thiadiazole Derivatives: Synthesis, Molecular Docking and Pharmacological Study
Volume: 13 Issue: 3
Author(s): Thoraya A. Farghaly, Sobhi M. Gomha, Abdelwahed R. Sayed and Mohammed A. Khedr
Affiliation:
Keywords: Carbothioamides, hydrazonoyl halides, benzosuberone, thiazoles, thiadiazoles, antitumor agents.
Abstract: New thiazole and 1,3,4-thiadiazole derivatives were synthesized from the reaction of hydrazonoyl halides and each of 3-(4-fluorophenyl)-3,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-2(1H)-carbothioamide and (E)-3-[mercapto(phenylamino)methylene]-thiochroman-4-one, respectively. The structures of all the newly synthesized compounds were established by elemental and spectral analyses. All of the synthesized compounds were tested for anticancer activity against colon cancer cell line HT29, human breast cancer cells MCF-7 and human hepatocellular carcinoma cell line HepG2. Many derivatives of the tested compounds showed moderate to high anticancer activity. Also, molecular docking against HER2 kinase domain revealed high free binding energy and good binding mode. The structure activity relationship (SAR) of tested compounds was studied.
Export Options
About this article
Cite this article as:
A. Farghaly Thoraya, M. Gomha Sobhi, R. Sayed Abdelwahed and A. Khedr Mohammed, Hydrazonoyl Halides as Precursors for Synthesis of Bioactive Thiazole and Thiadiazole Derivatives: Synthesis, Molecular Docking and Pharmacological Study, Current Organic Synthesis 2016; 13 (3) . https://dx.doi.org/10.2174/1570179412666150817220018
DOI https://dx.doi.org/10.2174/1570179412666150817220018 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Current Drug Targets Immunosuppressive Drugs in HIV Disease
Current Topics in Medicinal Chemistry Potential Usage of ING Family Members in Cancer Diagnostics and Molecular Therapy
Current Drug Targets Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers
Current Drug Targets Targeting Ovarian Cancer-Initiating Cells
Anti-Cancer Agents in Medicinal Chemistry Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Current Pharmaceutical Design From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Ascorbic Acid: Its Role in Immune System and Chronic Inflammation Diseases
Mini-Reviews in Medicinal Chemistry The Effects of Kisspeptin in Human Reproductive Function – Therapeutic Implications
Current Drug Targets Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
Current Medicinal Chemistry Novel Next-Generation Sequencing and Networks-Based Therapeutic Targets: Realistic and More Effective Drug Design and Discovery
Current Pharmaceutical Design Phytosynthesized Nanoparticles for Effective Cancer Treatment: A Review
Nanoscience & Nanotechnology-Asia Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Clostridium Difficile Infection Following Chemotherapy
Recent Patents on Anti-Infective Drug Discovery STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Can Breast Cancer Stem Cells Evade the Immune System?
Current Medicinal Chemistry microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design